Position in ASRT
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$1,047,156
New position
Shares Held
54,940
first reported quarter
Ownership
0.850%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026SEI INVESTMENTS CO holds $466,534,849 across 39 Drug Manufacturers - Specialty & Generic names. ASRT ranks #29 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ELAN |
Elanco Animal Health Inc
|
5,650,393 | $135,213,903 | |
| 2 | ZTS |
Zoetis Inc.
|
667,165 | $78,865,573 | |
| 3 | VTRS |
Viatris Inc
|
3,720,915 | $50,269,560 | |
| 4 | TEVA |
Teva Pharmaceutical Industries Ltd
|
1,182,751 | $35,624,459 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
|
235,251 | $30,991,966 | |
| 6 | UTHR |
UNITED THERAPEUTICS Corp
|
28,421 | $16,853,083 | |
| 7 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
284,005 | $13,674,840 | |
| 8 | HLN |
Haleon plc
|
1,285,485 | $12,867,704 |
All Filings in ASRT
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,047,156 | 54,940 | Shares | Sole | 2026-05-13 | |
| No filing history on record for this holder in this stock. | ||||||